相关实验视频
Updated: Feb 18, 2026

08:47
Oral Health Assessment by Lay Personnel for Older Adults
Published on: February 2, 2020
13.8K
在门诊机构实施年龄友好型卫生系统:系统性审查
Rebecca J Howe1,2, Katherine Rieke1,3, Htun Ja Mai4
1VA Providence Healthcare System, THRIVE COIN, Providence, Rhode Island, USA.
Journal of the American Geriatrics Society
|February 16, 2026
概括
在门诊环境中实施年龄友好型卫生系统 (AFHS) 显示了整个4M框架的改进过程. 然而,对于老年人的特定策略和以患者为中心的结果,需要更多的研究.
科学领域:
- 老年学是一门学科.
- 医疗保健服务研究 医疗服务研究
- 实施科学 实施科学
背景情况:
- 年龄友好型卫生系统 (AFHS) 倡议利用4M框架 (重要的是什么,药物,心理辅导,流动性) 来增强对老年人的护理.
- 虽然对单个组件存在证据,但有限的数据指导了所有4M的门诊实施.
研究的目的:
- 系统地审查有关在门诊机构实施AFHS影响的证据.
- 确定有效的战略,将4M框架纳入老年人群的常规临床实践.
主要方法:
- 从2015年到2024年11月,对主要数据库 (Medline,EMBASE,CINAHL,Cochrane) 和clinicaltrials.gov进行了全面的搜索.
- 包括在内的比较研究在门诊环境中实施了所有4M,并使用GRADE方法评估了偏差风险,并总结了结果.
主要成果:
- 基于美国的12项研究表明,AFHS干预措施改善了所有4Ms的过程指标.
- 具体实施战略的有效性是不确定的,结果/结构性措施很少被报告.
- 研究的异质性和不良报告限制了研究结果的概括性.
结论:
- 在政策扩展之前,在门诊环境中需要标准化,以结果为重点的AFHS测量.
- 未来的研究应该优先考虑实施忠实性,强有力的结果评估,以及反映老年人的价值观和经验的措施.
相关概念视频
Documentation in Long-Term and Home Healthcare Setting
1.6K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.6K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
719
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
719
Pharmacodynamics in Geriatric Patients: Effects of Age
243
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
243
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
264
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
264
Drug Dosing: Geriatric Patients
286
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
286
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
271
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
271
